A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy

A Multicenter, Open-Label, Two-Arm Prospective Study to Evaluate the Impact of Patient Readiness to Self-Inject on Outcomes When Using the Copaxone® Prefilled Syringes [The READY Trial]

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00238654

Enrollment

257

Registered

2005-10-13

Start date

2003-05-31

Completion date

2008-07-31

Last updated

2011-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

This study has patients responding to two sets of surveys that will tell their doctor or nurse about their readiness to begin self-injection. In addition, patients will have their self-injection observed and evaluated on up to three visits

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Male or Female, 18 years of age or older, with diagnosis of RRMS 2. Naive to treatment or previously treated with an IFN.

Exclusion criteria

1. Not eligible for treatment based on clinical criteria and current indication. 2. Unable to respond to surveys or provide informed consent.

Design outcomes

Primary

Measure	Time frame
Adherence of self-injection assessed by self-report at each follow-up visit	12 months

Outcome results